Four things to know:
- The government will not recommend one drugmaker’s booster over another, federal officials told The New York Times. The U.S. will likely say that while it’s preferable to use a booster made by the same drugmaker that produced a person’s original vaccine, providers can use their discretion to offer boosters made by a different drugmaker.
- A National Institutes of Health study on mixing COVID-19 vaccine doses showed that people who were vaccinated with Johnson & Johnson’s COVID-19 shot would receive greater protection if they got a booster made by Moderna or Pfizer. It was published Oct. 13 in preprint server MedRxiv.
- The FDA is expected to approve Moderna and Johnson & Johnson boosters this week, greatly expanding the number of Americans eligible for COVID-19 boosters.
- State officials have been pushing for the option to mix and match COVID-19 boosters for weeks. Many say the option allows for a more streamlined booster rollout, as states often have a greater supply of one vaccine over the others.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
